Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M. C. Ruddy"'
Autor:
M C, Ruddy, W J, Mroczek
Publikováno v:
Pharmacotherapy. 13(3)
To compare the clinical safety and efficacy of ramipril, a new long-acting nonsulfhydryl inhibitor of angiotensin-converting enzyme (ACE), with enalapril.A randomized, double-blind trial.Multicenter trial involving 4 large teaching hospitals and 12 c
Autor:
Kenneth C. Lasseter, M. A. Weber, N. Brachfeld, M. C. Ruddy, J. M. McKenney, W. M. Bennett, R. L. Williams, W. J. Stein, M. P. Sambhi, John Lunn, J. Morganroth, Edward T. Zawada, J. W. Hollifield, W. M. Kirkendall, Marvin Moser, L. A. Gourley, Arthur S. Leon, K. Miller, Paul A. Abraham, R. P. Goodman, John J. Whalen, Jacqueline DeSilva
Publikováno v:
Clinical pharmacology and therapeutics. 49(3)
Benazepril hydrochloride is a new angiotensin-converting enzyme inhibitor. In a multicenter study, 206 patients with mild to moderate hypertension were randomized to receive benazepril at a dose of 2, 5, 10, or 20 mg, hydrochlorothiazide, 25 mg, or p
Autor:
M. C. Ruddy, O. Vesterqvist, V. Campese, K B Brosnihan, Carlos M. Ferrario, W. Liao, C.E. Grim, Ronald D. Smith, Carla Yunis
Publikováno v:
American Journal of Hypertension. 13:S23
Autor:
W. B. Smith, Z. Ge, W. Liao, R. D. Smith, Carlos M. Ferrario, Clarence E. Grim, M. F. Habashy, Vito M. Campese, R. Vargas, M. C. Ruddy, K. C. Lasseter, C. L. Delaney
Publikováno v:
Journal of Hypertension. 18:S52
Publikováno v:
Journal of Hypertension. 18:S160
Autor:
M C, Ruddy
Publikováno v:
Annals of internal medicine. 83(2)
Autor:
M Aurell, Jean E. Sealey, M C Ruddy, B Dharmgrongartama, John H. Laragh, T E Hesson, Steven A. Atlas
Publikováno v:
The Journal of clinical investigation. 73(2)
Inactive renin comprises well over half the total renin in normal human plasma. There is a direct relationship between active and inactive renin levels in normal and hypertensive populations, but the proportion of inactive renin varies inversely with
Publikováno v:
The Journal of rheumatology. 14(3)
A selective antagonist of S2-serotonergic receptors, ketanserin, was administered intravenously during right heart catheterization to 14 patients with pulmonary hypertension complicating systemic sclerosis. A significant reduction in pulmonary vascul
Autor:
M C Ruddy
Publikováno v:
Hypertension. 3:277-278